ATLAS / Macro Radar / Reporting / VRXA

Veraxa Biotech Holding AG (VRXA) reporting calendar

Veraxa Biotech Holding AG files periodic reports with the SEC as VRXA on None. Atlas tracks 1 filed reports for this issuer, each linked to its original EDGAR accession.

Latest report
20-F
Period ended
31 Dec 2025
Filed
16 Jun 2026
Reports on record
1
Open VRXA market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
20-F31 Dec 202516 Jun 2026167 days0001829126-26-006546

Source: SEC EDGAR company submissions for CIK 0002079109. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.